Five-year evolution of drug prescribing in a university adult intensive care unit

por Voirol, P, Eggimann, P, Carron, C, Pannatier, A, Chiolero, R, Wasserfallen, JB
Publicado 2010

Risk factors for hypertriglyceridemia in the intensive care unit: an exploratory study

por Devaud, JC, Voirol, P, Marques-Vidal, P, Tappy, L, Rodondi, N, Chiolero, R, Berger, MM, Pannatier, A
Publicado 2010

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage

por Schneider, AS, Voirol, P, Perez, M, Schoettker, P, Wasserfallen, JB, Angelillo-Scherrer, A, Chiolero, R, Cotting, J, Eggimann, P
Publicado 2009

Safety of activated recombinant factor VII in patients with circulatory assist devices

por Schneider, AS, Tozzi, P, Voirol, P, Schoettker, P, Perez, MH, Angelillo-Scherrer, A, Wasserfallen, J, Chiolero, R, Cotting, J, Von Segesser, L, Eggimann, P
Publicado 2009

Guidelines for a training programme in intensive care medicine

por Thijs, L. G., Baltopoulos, G., Bihari, D., Burchardi, H., Carlet, J., Chioléro, R., Dragsted, L., Edwards, D. J., Ferdinande, P., Giunta, F., Kari, A., Kox, W., Planas, M., Vincent, J. L., Pfenninger, J., Edberg, K. E., Floret, D., Leijala, M., Tegtmeyer, F. K.
Publicado 1996